Skip to main content

Table 1 Characteristics of patients with and without anti-CCP antibodie

From: The relationship between the presence of anti-cyclic citrullinated peptide antibodies and clinical phenotype in very early rheumatoid arthritis

 

anti-CCP positive (n = 48)

anti-CCP negative (n = 44)

P value

Female (n (%))

28 (58.3%)

22 (50.0%)

0.42*

Age at inclusion, years (mean ± standard deviation)

56.6 ± 15.0

61.5 ± 14.7

0.12**

Ethnicity - Caucasian (n (%))

38 (79.2%)

39 (88.6%)

0.22*

Smoking status - Current/ever smoked (n (%))

31 (64.6%)

28 (63.6%)

0.92*

Symptom duration, days (mean ± standard deviation)

49.3 ± 20.2

56.4 ± 22.3

0.12**

Mode of onset (n (%))

   

Acute

25 (52.1%)

25 (56.8%)

0.65*

Insidious

21 (43.8%)

18 (40.9%)

 

Unspecified

2 (4.16%)

1 (2.27%)

 

Morning Stiffness

   

Duration, mins (mean ± standard deviation)

93.3 ± 89.5

123.8 ± 92.8

0.11**

No. patients ≥60 mins (n (%))

28 (58.3%)

32 (72.7%)

0.15*

Symmetry (n (%))

35 (72.9%)

33 (75.0%)

0.82*

Hand joint involvement (n (%))

43 (89.6%)

41 (93.2%)

0.54*

≥ 3 joint areas involved (n (%))

31 (64.6%)

30 (68.2%)

0.63*

Nodules (n (%))

2 (4.17%)

1 (2.27%)

0.61*

Erosions (n (%))

1 (2.08%)

2 (4.54%)

0.51*

Rheumatoid factor positive (n (%))

40 (83.3%)

5 (11.4%)

< 0.001*

1987 ACR criteria for RA

   

Total No. (mean ± standard deviation)

3.73 ± 1.09

3.23 ± 1.14

0.03**

No. fulfilling ≥ 4 criteria (n (%))

28 (58.3%)

16 (36.4%)

0.04*

Tender joint count (max 68) (mean ± standard deviation)

8.33 ± 7.80

9.66 ± 8.90

0.45**

Swollen joint count (max 66) (mean ± standard deviation)

5.79 ± 4.51

7.07 ± 5.83

0.25**

ESR mm/hr (mean ± standard deviation)

32.3 ± 20.1

38.7 ± 29.3

0.23**

CRP mg/L (mean ± standard deviation)

29.0 ± 27.0

31.4 ± 30.8

0.70**

  1. Statistical test applied: *Chi-squared test, **Unpaired student t-test